EH

重组新蛭素（酵母，中国人民解放军军事医学科学院/北京三有利和泽生物科技）

Report date: 2026/05/26 20:00:28

Base Information

Drug NameEH
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProthrombin inhibitors
TargetsProthrombin
Therapy Area/IndicationsVenous ThrombosisAcute Coronary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Sh Biotechnology Co LtdChinese Academy Of Military Medical Sciences
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Sh Biotechnology Co LtdInstitute Of Radiation And Radiation Medicine, Chinese Academy Of Military Medical Sciences
Inactive CompaniesN/A
Active IndicationsAcute Coronary Syndrome
Inactive IndicationsVenous Thrombosis

Other Information

ATC CodeN/A
Related LinksN/A